fig1
![Dissecting molecular mechanisms of immune microenvironment dysfunction in multiple myeloma and precursor conditions](https://image.oaes.cc/a1fcd85f-b352-4d0d-88c7-1a8ec2074469/5718.fig.1.jpg)
Figure 1. FDA-approved drugs for multiple myeloma and date of their first approval.
Figure 1. FDA-approved drugs for multiple myeloma and date of their first approval.
All published articles are preserved here permanently:
https://www.portico.org/publishers/oae/